ARQT stock news · Arcutis Biotherapeutics
Get alerts for ARQT
Follow Arcutis Biotherapeutics (ARQT) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ARQTFree on the App Store and Google Play, or on the web.
An insider at Arcutis Biotherapeutics sold about $1.4 million worth of shares.
NeutralA filing reports that an Arcutis insider sold about $1.4 million in shares. It gives no reason or business update, so the story does not change the company's outlook.